These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1702632)
1. Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine. Schwartz EL; Chamberlin H; Brechbühl AB Biochem Pharmacol; 1990 Dec; 40(11):2449-55. PubMed ID: 1702632 [TBL] [Abstract][Full Text] [Related]
2. Enhanced mitogenic responsiveness to granulocyte-macrophage colony-stimulating factor in HL-60 promyelocytic leukemia cells upon induction of differentiation. Schwartz EL; Maher AM Cancer Res; 1988 May; 48(10):2683-7. PubMed ID: 2834046 [TBL] [Abstract][Full Text] [Related]
3. Regulation of c-myc expression by granulocyte-macrophage colony-stimulating factor in human leukemia cells. Schwartz EL; Chamberlin H; Brechbühl AB Blood; 1991 Jun; 77(12):2716-23. PubMed ID: 1646047 [TBL] [Abstract][Full Text] [Related]
4. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells. Cheng HW; Armstrong RD; Sadée W Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells. French BT; Patrick DE; Grever MR; Trewyn RW Cancer Chemother Pharmacol; 1990; 27(3):171-7. PubMed ID: 2265452 [TBL] [Abstract][Full Text] [Related]
6. Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanine. French BT; Patrick DE; Grever MR; Trewyn RW Proc Natl Acad Sci U S A; 1991 Jan; 88(2):370-4. PubMed ID: 1988936 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes. Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells. Ishiguro K; Sartorelli AC Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287 [TBL] [Abstract][Full Text] [Related]
9. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation. Wu J; Zhu JQ; Han KK; Zhu DX Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686 [TBL] [Abstract][Full Text] [Related]
10. Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells. Wickstrom EL; Bacon TA; Gonzalez A; Lyman GH; Wickstrom E In Vitro Cell Dev Biol; 1989 Mar; 25(3 Pt 1):297-302. PubMed ID: 2647708 [TBL] [Abstract][Full Text] [Related]
11. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media. Bacon TA; Wickstrom E Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946 [TBL] [Abstract][Full Text] [Related]
12. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate. Harel-Bellan A; Farrar WL J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231 [TBL] [Abstract][Full Text] [Related]
13. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines. Darling D; Tavassoli M; Linskens MH; Farzaneh F Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells. Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636 [TBL] [Abstract][Full Text] [Related]
15. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin. Stöcker U; Schaefer A; Marquardt H Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009 [TBL] [Abstract][Full Text] [Related]
16. Retinoic-acid-induced modulation of c-myc not dependent on its continued presence: possible role in pre-commitment for HL-60 cells. Guernsey DL; Yen A Int J Cancer; 1988 Oct; 42(4):576-81. PubMed ID: 2459072 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase mutations in thioguanine-resistant HL-60 human leukemia cells. Monnat RJ Cancer Res; 1989 Jan; 49(1):81-7. PubMed ID: 2908855 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells. Schwartz EL; Blair OC; Sartorelli AC Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells. Ishiguro K; Schwartz EL; Sartorelli AC J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322 [TBL] [Abstract][Full Text] [Related]
20. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines. Arsura M; Luchetti MM; Erba E; Golay J; Rambaldi A; Introna M Blood; 1994 Apr; 83(7):1778-90. PubMed ID: 8142646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]